CutisPharma names Neal Muni as Chief Executive Officer President Is Promoted at Wilmington-based Specialty Pharmaceutical Firm
CutisPharma Closes Equity Financing with Ampersand CutisPharma, a specialty pharmaceutical company focusing on the development and commercialization of value-added kits for the compounding pharmacy market,...
If you are a prescriber/user of FIRST® Unit of Use Compounding kits and are being told that the product has been discontinued, you have unfortunately been impacted, by First Databank’s editorial decision to stop listing compounding kits in their drug database.
Read the White Paper
As pharmaceutical compounding continues to grow and evolve, there will be many innovations that will come to enable pharmacists to compound more accurately and more efficiently.
Compounding kits are one example as described in this paper. READ MORE